Samuel Salvaggio

Samuel Salvaggio, PhD, is a Senior Trial Design Lead at One2Treat, focusing on comprehensive assessments of treatment effects since September 2023. Concurrently, Samuel serves as a Lecturer at Ecole de Santé Publique de l'ULB, teaching Biostatistics in the Specialized Master in Public Health Methodology. Previous roles include research biostatistician at IDDI, where Samuel contributed to experimental design and data analysis for the BENEFIT project, and various positions at Université catholique de Louvain, including postdoctoral researcher in cognitive neuroscience and scientific collaborator. Samuel's academic credentials include a PhD in Cognitive Neuroscience and a Master's degree in Research Methodology & Cognitive Sciences from Université catholique de Louvain.